- Home
- IONS vs CWST Comparison
IONS vs CWST Comparison
Compare IONS & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IONS
- CWST
- Stock Information
- Founded
- IONS 1989
- CWST 1975
- Country
- IONS United States
- CWST United States
- Employees
- IONS N/A
- CWST N/A
- Industry
- IONS Biotechnology: Pharmaceutical Preparations
- CWST Environmental Services
- Sector
- IONS Health Care
- CWST Utilities
- Exchange
- IONS Nasdaq
- CWST Nasdaq
- Market Cap
- IONS 6.0B
- CWST 6.2B
- IPO Year
- IONS 1991
- CWST 1997
- Fundamental
- Price
- IONS $30.17
- CWST $111.51
- Analyst Decision
- IONS Buy
- CWST Buy
- Analyst Count
- IONS 19
- CWST 5
- Target Price
- IONS $59.24
- CWST $117.75
- AVG Volume (30 Days)
- IONS 1.5M
- CWST 374.5K
- Earning Date
- IONS 05-06-2025
- CWST 04-24-2025
- Dividend Yield
- IONS N/A
- CWST N/A
- EPS Growth
- IONS N/A
- CWST N/A
- EPS
- IONS N/A
- CWST 0.23
- Revenue
- IONS $705,138,000.00
- CWST $1,557,283,000.00
- Revenue This Year
- IONS N/A
- CWST $17.38
- Revenue Next Year
- IONS $25.71
- CWST $6.73
- P/E Ratio
- IONS N/A
- CWST $491.93
- Revenue Growth
- IONS N/A
- CWST 23.15
- 52 Week Low
- IONS $29.61
- CWST $86.41
- 52 Week High
- IONS $52.34
- CWST $116.31
- Technical
- Relative Strength Index (RSI)
- IONS 37.05
- CWST 53.75
- Support Level
- IONS $31.04
- CWST $109.98
- Resistance Level
- IONS $33.76
- CWST $113.47
- Average True Range (ATR)
- IONS 1.16
- CWST 2.67
- MACD
- IONS -0.30
- CWST 0.20
- Stochastic Oscillator
- IONS 10.92
- CWST 79.77
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.